Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: A randomized study.

CONCLUSIONS: Results from this small pilot RCT suggest beneficial effects of both clozapine and ziprasidone in the treatment of cannabis use disorders in psychotic patients. Larger-scale RCTs are needed in order to assess advantages and disadvantages of the different SGAs in dually diagnosed populations. (Am J Addict 2014;9999:1-5). PMID: 24628830 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24628830?dopt=Abstract

Source: American Journal on Addictions - March 15, 2014 Category: Addiction Authors: Schnell T, Koethe D, Krasnianski A, Gairing S, Schnell K, Daumann J, Gouzoulis-Mayfrank E Tags: Am J Addict Source Type: research